Genetics of Cardiovascular Reactivity in Black Youth

Sponsor
University of Tennessee (Other)
Overall Status
Completed
CT.gov ID
NCT00064675
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
500
59

Study Details

Study Description

Brief Summary

To evaluate individual differences in cardiovascular responses to acute stress in Black adolescents.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    BACKGROUND:

    The prevalence and severity of essential hypertension (EH) are greater among Black Americans than other ethnic groups in the U.S. Blacks are at increased risk for target organ damage from elevated blood pressure, including heart disease, stroke, and endstage renal failure. There are significant ethnic differences in cardiovascular reactivity (CVR) to stress, which is a risk factor for elevated blood pressure. Studies have shown that CVR to stress is stable over time, heritable, and predictive of future elevations in blood pressure and the development of essential hypertension. These properties make measures of CVR a valuable intermediate for genetic studies of hypertensive risk.

    DESIGN NARRATIVE:

    The genetic epidemiology study will test the hypothesis that individual differences in CVR to acute stress in Black youth are associated with well defined polymorphisms in candidate genes related to blood pressure including: 1) alpha- and beta-adrenergic receptor genes; 2) genes involved in catecholamine metabolism; 3) genes involved in endocrine function; 4) genes involved in the renin angiotensin system. By focusing on normotensive youth at risk for developing essential hypertension, the investigators hope to identify genes associated with the onset, rather than the sequelae, of hypertension. Moreover, given that CVR to acute stress is defined as a change in cardiovascular function evoked by an environmental manipulation of stress, the research is inherently a study of gene-environment interactions.

    A total of 500 unrelated Black adolescents and young adults (equal numbers of males and females), 15-21 years of age will be studied. Buccal cell samples will be collected for DNA extraction from all subjects for genetic association analyses. Impedance cardiography and blood pressure monitoring will be used to assess components of CVR to stress during video game, mental arithmetic, cold pressor, and whole body cold exposure tasks, all of which have been utilized or developed in the laboratory. Various methods will be used to evaluate genetic associations with CVR to acute stress, including analyses of single nucleotide polymorphisms and haplotypes. Supplementary analyses will evaluate potential gene-gene interactions and additional gene-environment interactions involving chronic environmental stress.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Genetics of Cardiovascular Reactivity in Black Youth
    Study Start Date :
    Jul 1, 2003
    Actual Primary Completion Date :
    Jun 1, 2008
    Actual Study Completion Date :
    Jun 1, 2008

    Outcome Measures

    Primary Outcome Measures

    1. genes associated with hyperreactivity [done]

      several genes associated with reactivity

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 21 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    African American non-hypertensive, no chronic disease which would affect blood pressure

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Tennessee
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Bruce Alpert, University of Tennessee Health Science Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Tennessee
    ClinicalTrials.gov Identifier:
    NCT00064675
    Other Study ID Numbers:
    • 1229
    • R01HL072375
    • R01HL068971-04
    First Posted:
    Jul 14, 2003
    Last Update Posted:
    Apr 8, 2013
    Last Verified:
    Apr 1, 2013
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 8, 2013